1743. Deputy Rose Conway-Walsh asked the Minister for Health when she expects an outcome from the application for pricing and reimbursement of omaveloxolone (Skyclarys) for the treatment of Friedreich’s Ataxia in adults and adolescents aged 16 years and older; if not yet known, the efforts that will be made in the interim to support those diagnosed with Friedreich’s Ataxia who are waiting on the outcome of this process; and if she will make a statement on the matter. [18722/26]

Summary

1743. Deputy Rose Conway-Walsh asked the Minister for Health when she expects an outcome from the application for pricing and reimbursement of omaveloxolone (Skyclarys) for the treatment of Friedreich’s Ataxia in adults and adolescents aged 16 years and older; if not yet known, the efforts that will be made in the interim to support those diagnosed with Friedreich’s Ataxia who are waiting on the outcome of this process; and if she will make a statement on the matter. [18722/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 18 March 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.